Intratumoral heterogeneity, its contribution to therapy resistance and methodological caveats to assessment
Front Oncol
.
2014 Jun 10:4:142.
doi: 10.3389/fonc.2014.00142.
eCollection 2014.
Authors
Mirjam Renovanz
1
,
Ella L Kim
1
Affiliation
1
The Translational Neurooncology Research Group, Department of Neurosurgery, Johannes Gutenberg University Medical Centre , Mainz , Germany.
PMID:
24959421
PMCID:
PMC4050363
DOI:
10.3389/fonc.2014.00142
No abstract available
Keywords:
anti-cancer therapy; cancer; intratumor heterogeneity; tumor recurrence.
Publication types
Review